16 / 60
16
Scientific programme
Thursday, 28 May 2015
RC-1
Research Consortia Session
15:00–16:30
Alsh 1/2
ADHD and substance abuse: Causes and options for
treatment and prevention
Chairs:
G. van de Glind, The Netherlands
J. A. Ramos-Quiroga, Spain
RC-1-001 ADHD, substance abuse disorders and
genetics
J. A. Ramos-Quiroga, Spain
RC-1-002 Inhibition deficits and substance abuse
disorders development
I. Ivanov, USA
RC-1-003 Cognitive behavioral therapy for patients
with ADHD and substance use disorders
K. van Emmerik-van Oortmerssen, The
Netherlands
E. Vedel, W. van den Brink, R. Schoevers
RC-1-004 Current practice in Belgium on ADHD and
substance abuse disorders
F. Matthys, Belgium
16:30 – 17:00
Break
HT-4
Hot Topic Symposium
17:00–18:30
Lomund Auditorium
Real outcomes of ADHD
Chairs:
O. Tucha, The Netherlands
N.N.
HT-4-001 Neuropsychology of adult ADHD – search-
ing for the impact on real life
O. Tucha, The Netherlands
HT-4-002 School underachievement
A. B. M. Fuermaier, The Netherlands
HT-4-003 Mortality in children, adolescents and
adults with ADHD
S. Dalsgaard, Denmark
HT-4-004 Risky sexual behaviour and pregnancy in
adolescence with ADHD
D. E. Sarver, USA
HT-5
Hot Topic Symposium
17:00–18:30
Dochart 1/2
The current state of neurofeedback in ADHD
Chairs:
A. Fallgatter, Germany
K. Rubia, United Kingdom
HT-5-001 fMRI neurofeedback in adolescents with
ADHD
K. Rubia, United Kingdom
HT-5-002 NIRS neurofeedback in ADHD
A. Fallgatter, Germany
HT-5-003 A randomized controlled multicentre
study on the efficacy of slow cortical po-
tential neurofeedback in ADHD
D. Brandeis, Germany
HT-5-004 Neurofeedback in ADHD: Meta-analysis,
current state and future perspectives
M. Arns, The Netherlands
YS-2
Young Scientist Session
17:00–18:30
Boisdale 2
Young Scientists´Session II
Chairs:
L. A. Rohde, Brazil
S. Walitza, Switzerland
YS-2-001 Has the prevalence of ADHD increased
during the last decade?
M. Rydell, Sweden
YS-2-002 Birth weight predicts adolescent brain
volume in participants with ADHD, unaf-
fected siblings and control participants
C. Greven, The Netherlands
YS-2-003 Antisocial outcomes and psychiatric, social
and familial risk factors – a nationwide
controlled Danish registry study
C. M. Jensen, Denmark